Originally posted by Roy
View Post
No one has died from the Omicron coronavirus variant in a study of Johnson & Johnson's (JNJ.N) COVID-19 vaccine in South Africa, one of the co-lead investigators of the study said on Tuesday.
"Although we have had a lot of breakthrough infections there has been very little hospital admission in comparison to the Delta period. And as of today we have had no one who has died from Omicron from the J&J study, so that's the good news, it shows again that the vaccine is effective against severe disease and death," South African Medical Research Council president Glenda Gray told a news conference.
https://www.reuters.com/world/africa...ys-2021-12-14/
"Although we have had a lot of breakthrough infections there has been very little hospital admission in comparison to the Delta period. And as of today we have had no one who has died from Omicron from the J&J study, so that's the good news, it shows again that the vaccine is effective against severe disease and death," South African Medical Research Council president Glenda Gray told a news conference.
https://www.reuters.com/world/africa...ys-2021-12-14/
A study out of South Africa found the country may have already passed the peak of it omicron-fueled surge in cases of the coronavirus, with data suggesting the variant has not caused a corresponding jump in hospitalizations and deaths.
https://thehill.com/policy/healthcar...-with-no-major
https://thehill.com/policy/healthcar...-with-no-major
Comment